StockNews.com began coverage on shares of Fanhua (NASDAQ:FANH – Free Report) in a report issued on Sunday morning. The brokerage issued a hold rating on the financial services provider’s stock.
Fanhua Trading Down 1.3 %
Shares of FANH opened at $1.53 on Friday. The company’s 50-day moving average price is $1.40 and its 200 day moving average price is $2.15. Fanhua has a 12-month low of $1.04 and a 12-month high of $7.48. The firm has a market cap of $86.76 million, a P/E ratio of 2.10 and a beta of -0.06.
Hedge Funds Weigh In On Fanhua
A hedge fund recently raised its stake in Fanhua stock. Dimensional Fund Advisors LP raised its position in shares of Fanhua Inc. (NASDAQ:FANH – Free Report) by 11.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 466,320 shares of the financial services provider’s stock after buying an additional 48,383 shares during the period. Dimensional Fund Advisors LP owned about 0.82% of Fanhua worth $930,000 as of its most recent filing with the Securities & Exchange Commission. 26.72% of the stock is currently owned by hedge funds and other institutional investors.
About Fanhua
Fanhua Inc, together with its subsidiary, distributes insurance products in China. It operates through two segments, Insurance Agency and Claims Adjusting. The Insurance Agency segment provides property and casualty insurance products that primarily include individual accident, travel, homeowner, and indemnity medical insurance products; and life insurance products, such as individual health, individual whole life, individual term life, individual endowment life, and individual annuity, as well as participating insurance products.
Further Reading
- Five stocks we like better than Fanhua
- Health Care Stocks Explained: Why You Might Want to Invest
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Fanhua Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fanhua and related companies with MarketBeat.com's FREE daily email newsletter.